ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TRX Tissue Regenix Group Plc

61.50
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00BNTXR104 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 61.50 61.00 62.00 61.50 61.50 61.50 2,000 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 24.48M -2.7M -0.0382 -16.10 43.4M
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 61.50p. Over the last year, Tissue Regenix shares have traded in a share price range of 49.00p to 71.50p.

Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £43.40 million. Tissue Regenix has a price to earnings ratio (PE ratio) of -16.10.

Tissue Regenix Share Discussion Threads

Showing 12501 to 12520 of 14750 messages
Chat Pages: Latest  506  505  504  503  502  501  500  499  498  497  496  495  Older
DateSubjectAuthorDiscuss
24/1/2020
16:38
If its to believed that today was Woodies final day to offload then we should see a blue monday and an RNS by Wednesday.
See whats in the news over the weekend.
Enjoy all :)

theapplefreak
24/1/2020
15:57
Entire stock been turned over in last few weeks

Somewhere within that you'd hope its churned into stronger hands who understand the potential

the stigologist
24/1/2020
14:47
Haha I think youre pirate!

Buys still appearing as Sells...

theapplefreak
24/1/2020
12:48
You said that what, a week or 2 ago.
Doesn't seem to have moved....

theapplefreak
24/1/2020
12:28
Keep an eye on Orm it might do a bagger in few days!Based on Cash
costax1654x
24/1/2020
11:57
New dummy sell tried for all my holding here 2.6 mil. @1.21. And they want them all. They need your shares :)
monster500
24/1/2020
11:23
The overhang ending will see stock spike straight up.

There might be second spike on RNS confirming it.

No reason for this to trade sub NAV.

Sitting duck for predators. This technology is super valuable. $200m of sales potential in osteobiologics

3p is NAV

Takeout would be at premium to NAV.

Of course wouldn't need to sell whole business. Sell off one division at above NAV will make point that market is undervaluing the whole.

Not been here as long as others. Could the JV partner buy in the JV interest ?

the stigologist
24/1/2020
11:22
Buys showing as sells
herb clark
24/1/2020
11:15
Nice move this morning back in the right direction.
Either people have came to their senses, or all the weak hands finally left!
Or course link may have finished.

Who knows, at least its blue!

theapplefreak
24/1/2020
10:20
1.20 to buy and sell
herb clark
24/1/2020
10:14
100% likelihood of recapitalisation
with I'd guess disaggregated likelihoods of...
12.5% takeover
25% disposals/divestment
50% placing
50% rights issue
100% cash management/cash generation

the stigologist
24/1/2020
10:06
How likely is a placing in the next few months?
herb clark
24/1/2020
09:52
Buy when others are fearful
the stigologist
24/1/2020
09:37
Still can’t bring myself to buy. Not because the Stig isn’t correct but rather AIM is broken and no one has a clue what it will do. Shame. Used to be good to be in AIM ten years ago.
charlesjames1
24/1/2020
09:15
the stigologist - share price is now 1.15p. Bought some yesterday at 1.20p. Should I be happy now?
justincase999
24/1/2020
08:43
This is and remains my position.

Bought more. Happy to buy from the stupid/desperate.

We knew they were looking at 'recapitalisation' (that can be via placing, rights issue, disposals/divestments) but they've already demonstrated they can expand cash runway in meantime whilst they consider best options

From 'at least to end of March' to 'at least to end of April'

That is a full 3 months which gives plenty of time for more
-cash management, cash generation etc
-disposals/divestments
-placing / rights issue (I have stated my preference for a rights issue as it gives holder pre-emption rights to the clear and evident mega upside)

With 3 months cash runway they can leave the worst of those recapitalisation options (placing) to March. Right Issue might require a bit more time to arrange, get documentation sent out etc.

Either way

TRX is only at 1.2p because of Woodford overhang

NAV/share is 3p+

Typically in growth industries and market-leading Companies tend to trade at premia to NAV because that is what a new entrant would have to pay to replicate that position

So we should be looking at a share price of 6p+

The fact the Chairman John Samuel bought at 10p is a further signal that value is SIGNIFICANTLY in excess of 1.2p here

the stigologist
24/1/2020
05:14
Stig, yet again, you got it wrong, call it a day!

cheers

Your mate

dudishes
23/1/2020
18:41
Perhaps if the TRX Board were that clever they would be asking for it.
nxc
23/1/2020
18:04
I’m u
bmdyson1
23/1/2020
17:11
Completely unnecessary response - I have been there in not dis-similar situations and I suggest that taking on additional debt at this stage would be foolhardy - a placing is the most straightforward way of recapitalising the company - the funds may come from a trade investor or a combination of institutional and retail investors ( Avacta's recent placing is a good example of what can be achieved). I am not carping or suggesting the Board lead an extravagant lifestyle - what I would question is the validity of taking on venture debt in a Company such as TRX - I can imagine the discussions that would have taken place at the time vis a vis dilution - all I would say is that taking on debt in such early stage companies is fraught with danger and best avoided as in essence you can end up betting the farm and the ultimate losers are the Shareholders. I have huge sympathy for the Board in terms of their inability to communicate with the clarity we all want - they are damned if they do and damned if they do not - the rules are such that communications on funding are limited. It would not surprise me if they are having "strategic" discussions with potential acquirers for all or part of the business - I certainly would be if I was at the helm.
nxc
Chat Pages: Latest  506  505  504  503  502  501  500  499  498  497  496  495  Older

Your Recent History

Delayed Upgrade Clock